ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

RCEL Avita Medical Inc

8,65
0,25 (2,98%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Avita Medical Inc RCEL NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,25 2,98% 8,65 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,41 8,4031 8,96 8,65 8,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.4.202423:05GLOBEAVITA Medical to Announce First Quarter 2024 Financial..
10.4.202423:11GLOBEAVITA Medical Updates Expected First Quarter 2024 Revenue
29.2.202422:02GLOBEAVITA Medical Submits Response to FDA, Resuming Review Clock..
29.2.202415:00GLOBEAVITA Medical to Present at TD Cowen 44th Annual Health Care..
23.2.202415:01GLOBEAVITA Medical to Host Investor Webinar Briefing
22.2.202422:02EDGAR2Form 8-K - Current report
22.2.202422:01GLOBEAVITA Medical Reports Fourth Quarter and Full-Year 2023..
01.2.202422:10GLOBEAVITA Medical to Announce Fourth Quarter and Full Year 2023..
10.1.202422:05EDGAR2Form 8-K - Current report
10.1.202422:01GLOBEAVITA Medical Announces Exclusive Distribution Agreement..
10.1.202415:01GLOBEAVITA Medical Announces Preliminary 2023 Financial..
05.1.202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202415:00GLOBEAVITA Medical to Present at the 42nd Annual J.P. Morgan..
04.12.202315:00GLOBEAVITA Medical to Host Investor Webinar Briefing
21.11.202322:15GLOBEAVITA Medical to Present at the Piper Sandler 35th Annual..
21.11.202315:10IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
20.11.202322:15GLOBEAVITA Medical Updates Full Year 2023 Guidance
09.11.202322:09EDGAR2Form 8-K - Current report
09.11.202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:01GLOBEAVITA Medical Reports Third Quarter Financial Results with..
09.11.202315:00GLOBEAVITA Medical Announces Distribution Partnership with..
23.10.202322:36EDGAR2Form 8-K - Current report
19.10.202322:05GLOBEAVITA Medical to Announce Third Quarter 2023 Financial..
18.10.202315:07EDGAR2Form 8-K - Current report
18.10.202315:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18.10.202315:00GLOBEAVITA Medical Announces Preliminary Third Quarter 2023..
02.10.202314:56EDGAR2Form 8-K - Current report
25.9.202314:00GLOBEAVITA Medical Receives Best Product Award at the American..
21.9.202322:30GLOBEAVITA Medical to Present at the Cantor Global Healthcare..
08.9.202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202300:45GLOBEAVITA Medical to Participate in Upcoming Investor..
14.8.202314:00GLOBEAVITA Medical to Host Investor Webinar Briefing
10.8.202322:05EDGAR2Form 8-K - Current report
10.8.202322:01GLOBEAVITA Medical Reports Second Quarter Financial Results
20.7.202322:05GLOBEAVITA Medical to Announce Second Quarter 2023 Financial..
30.6.202322:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
30.6.202300:21GLOBEAVITA Medical Submits FDA PMA Supplement for RECELL GO
26.6.202314:00GLOBEAVITA Medical Rejoins the Russell 3000 Index
16.6.202320:47GLOBEAVITA Medical Announces FDA Approval of RECELL for Skin..
15.6.202322:05GLOBEAVITA Medical Announces Appointment of David O’Toole as..
08.6.202302:00GLOBEAVITA Medical Announces FDA Approval of RECELL for Treatment..
16.5.202300:31GLOBEAVITA Medical to Host Investor Webinar Briefing
11.5.202322:12GLOBEAVITA Medical Reports First Quarter Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock